{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:18:35Z","timestamp":1790399915077,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41401-022-00925-3","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T07:03:17Z","timestamp":1656572597000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term treatment with the mPXR agonist PCN promotes hepatomegaly and lipid accumulation without hepatocyte proliferation in mice"],"prefix":"10.1038","volume":"44","author":[{"given":"Yi-fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-cheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"925_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","volume":"92","author":"SA Kliewer","year":"1998","unstructured":"Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998;92:73\u201382.","journal-title":"Cell"},{"key":"925_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.tips.2012.07.003","volume":"33","author":"J Gao","year":"2012","unstructured":"Gao J, Xie W. Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci. 2012;33:552\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"925_CR3","first-page":"1325","volume":"29","author":"L Drocourt","year":"2001","unstructured":"Drocourt L, Pascussi JM, Assenat E, Fabre JM, Maurel P, Vilarem MJ. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. Drug Metab Dispos. 2001;29:1325\u201331.","journal-title":"Drug Metab Dispos"},{"key":"925_CR4","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1124\/dmd.107.016832","volume":"35","author":"W Bhadhprasit","year":"2007","unstructured":"Bhadhprasit W, Sakuma T, Hatakeyama N, Fuwa M, Kitajima K, Nemoto N. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Drug Metab Dispos. 2007;35:1880\u20135.","journal-title":"Drug Metab Dispos"},{"key":"925_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mam.2009.04.002","volume":"30","author":"A Di Masi","year":"2009","unstructured":"Di Masi A, De Marinis E, Ascenzi P, Marino M. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Asp Med. 2009;30:297\u2013343.","journal-title":"Mol Asp Med"},{"key":"925_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425255.2012.685237","volume":"8","author":"Y Wang","year":"2012","unstructured":"Wang Y, Ong S, Chai S, Chen T. Role of CAR and PXR in xenobiotic sensing and metabolism. Expert Opin Drug Metab Toxicol. 2012;8:803\u201317.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"925_CR7","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/hep.28988","volume":"65","author":"GK Michalopoulos","year":"2017","unstructured":"Michalopoulos GK. Hepatostat: Liver regeneration and normal liver tissue maintenance. Hepatology. 2017;65:1384\u201392.","journal-title":"Hepatology"},{"key":"925_CR8","first-page":"1467","volume":"29","author":"J Staudinger","year":"2001","unstructured":"Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos. 2001;29:1467\u201372.","journal-title":"Drug Metab Dispos"},{"key":"925_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.30131","volume":"69","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, et al. Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice. Hepatology. 2019;69:343\u201358.","journal-title":"Hepatology"},{"key":"925_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/BJ20150734","volume":"473","author":"R Shizu","year":"2016","unstructured":"Shizu R, Abe T, Benoki S, Takahashi M, Kodama S, Miayata M, et al. PXR stimulates growth factor-mediated hepatocyte proliferation by cross-talk with the FOXO transcription factor. Biochem J. 2016;473:257\u201366.","journal-title":"Biochem J"},{"key":"925_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41401-021-00633-4","volume":"43","author":"X Yao","year":"2021","unstructured":"Yao X, Jiao T, Jiang Y, Fan S, Zhao Y, Yang X, et al. PXR mediates mifepristone-induced hepatomegaly in mice. Acta Pharmacol Sin. 2021;43:146\u201356.","journal-title":"Acta Pharmacol Sin"},{"key":"925_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1124\/dmd.120.000061","volume":"48","author":"T Jiao","year":"2020","unstructured":"Jiao T, Yao X, Zhao Y, Zhou Y, Gao Y, Fan S, et al. Dexamethasone-induced liver enlargement is related to PXR\/YAP activation and lipid accumulation but not hepatocyte proliferation. Drug Metab Dispos. 2020;48:830\u20139.","journal-title":"Drug Metab Dispos"},{"key":"925_CR13","doi-asserted-by":"publisher","first-page":"153520","DOI":"10.1016\/j.phymed.2021.153520","volume":"84","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yao X, Jiao T, Tian J, Gao Y, Fan S, et al. Schisandrol B promotes liver enlargement via activation of PXR and YAP pathways in mice. Phytomedicine. 2021;84:153520.","journal-title":"Phytomedicine"},{"key":"925_CR14","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.jpba.2020.113851","volume":"195","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Yao X, Fan S, Gao Y, Zhang H, Huang M, et al. Lipidomic profiling reveals triacylglycerol accumulation in the liver during pregnane X receptor activation-induced hepatomegaly. J Pharm Biomed Anal. 2021;195:113851.","journal-title":"J Pharm Biomed Anal"},{"key":"925_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00204-020-02955-4","volume":"95","author":"R Shizu","year":"2021","unstructured":"Shizu R, Ishimura M, Nobusawa S, Hosaka T, Sasaki T, Kakizaki S, et al. The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice. Arch Toxicol. 2021;95:1089\u2013102.","journal-title":"Arch Toxicol"},{"key":"925_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.apsb.2020.11.021","volume":"11","author":"Y Gao","year":"2021","unstructured":"Gao Y, Fan S, Li H, Jiang Y, Yao X, Zhu S, et al. Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation. Acta Pharm Sin B. 2021;11:727\u201337.","journal-title":"Acta Pharm Sin B"},{"key":"925_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep.32105","volume":"75","author":"S Fan","year":"2022","unstructured":"Fan S, Gao Y, Qu A, Jiang Y, Li H, Xie G, et al. YAP-TEAD mediates PPAR alpha-induced hepatomegaly and liver regeneration in mice. Hepatology. 2022;75:74\u201388.","journal-title":"Hepatology"},{"key":"925_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jpha.2020.04.004","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang Y, Guan L, Chen Y, Chen P, Sun J, et al. Lipidomics reveals carnitine palmitoyltransferase 1C protects cancer cells from lipotoxicity and senescence. J Pharm Anal. 2021;11:340\u201350.","journal-title":"J Pharm Anal"},{"key":"925_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0304-3835(96)04310-8","volume":"106","author":"P Carthew","year":"1996","unstructured":"Carthew P, Nolan BM, Edwards RE, Smith LL. The role of cell death and cell proliferation in the promotion of rat liver tumours by tamoxifen. Cancer Lett. 1996;106:163\u20139.","journal-title":"Cancer Lett"},{"key":"925_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.taap.2009.09.013","volume":"242","author":"A Kakehashi","year":"2010","unstructured":"Kakehashi A, Kato A, Inoue M, Ishii N, Okazaki E, Wei M, et al. Cytokeratin 8\/18 as a new marker of mouse liver preneoplastic lesions. Toxicol Appl Pharmacol. 2010;242:47\u201355.","journal-title":"Toxicol Appl Pharmacol"},{"key":"925_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cld.2015.01.005","volume":"19","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Ahmed A, Gish RG. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Clin Liver Dis. 2015;19:309\u201323.","journal-title":"Clin Liver Dis"},{"key":"925_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1124\/jpet.119.258632","volume":"371","author":"T Abe","year":"2019","unstructured":"Abe T, Shizu R, Sasaki T, Shimizu Y, Hosaka T, Kodama S, et al. Functional interaction between pregnane X receptor and Yes-associated protein in xenobiotic-dependent liver hypertrophy and drug metabolism. J Pharmacol Exp Ther. 2019;371:590\u2013601.","journal-title":"J Pharmacol Exp Ther"},{"key":"925_CR23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00204-008-0312-z","volume":"82","author":"CD Fisher","year":"2008","unstructured":"Fisher CD, Jackson JP, Lickteig AJ, Augustine LM, Cherrington NJ. Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. Arch Toxicol. 2008;82:959\u201364.","journal-title":"Arch Toxicol"},{"key":"925_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.apsb.2019.06.012","volume":"10","author":"Y Xing","year":"2020","unstructured":"Xing Y, Yan J, Niu Y. PXR: a center of transcriptional regulation in cancer. Acta Pharm Sin B 2020;10:197\u2013206.","journal-title":"Acta Pharm Sin B"},{"key":"925_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0163-7827(03)00051-1","volume":"43","author":"RA Coleman","year":"2004","unstructured":"Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res. 2004;43:134\u201376.","journal-title":"Prog Lipid Res"},{"key":"925_CR26","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1021\/acs.analchem.7b05395","volume":"90","author":"M Hol\u010dapek","year":"2018","unstructured":"Hol\u010dapek M, Liebisch G, Ekroos K. Lipidomic analysis. Anal Chem. 2018;90:4249\u201357.","journal-title":"Anal Chem"},{"key":"925_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","volume":"20","author":"T Wada","year":"2009","unstructured":"Wada T, Gao J, Xie W. PXR and CAR in energy metabolism. Trends Endocrinol Metab. 2009;20:273\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"925_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343\u201351.","journal-title":"J Clin Invest"},{"key":"925_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, Mccall S, Huang J, Yu X, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366\u201374.","journal-title":"Hepatology"},{"key":"925_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/egh.09.32","volume":"3","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol. 2009;3:445\u201351.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"925_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1172\/JCI8574","volume":"105","author":"EA Podrez","year":"2000","unstructured":"Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest. 2000;105:1095\u2013108.","journal-title":"J Clin Invest"},{"key":"925_CR32","doi-asserted-by":"publisher","first-page":"27816","DOI":"10.1074\/jbc.M109.022467","volume":"284","author":"LO Li","year":"2009","unstructured":"Li LO, Ellis JM, Paich HA, Wang S, Gong N, Altshuller G, et al. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J Biol Chem. 2009;284:27816\u201326.","journal-title":"J Biol Chem"},{"key":"925_CR33","doi-asserted-by":"crossref","unstructured":"Brejchova K, Radner FPW, Balas L, Paluchova V, Cajka T, Chodounska H, et al. Distinct roles of adipose triglyceride lipase and hormone-sensitive lipase in the catabolism of triacylglycerol estolides. Proc Natl Acad Sci USA. 2021; 118.","DOI":"10.1073\/pnas.2020999118"},{"key":"925_CR34","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN Van Der Veen","year":"2017","unstructured":"Van Der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859:1558\u201372.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"925_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","volume":"3","author":"Z Li","year":"2006","unstructured":"Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006;3:321\u201331.","journal-title":"Cell Metab"},{"key":"925_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2014.06.002","volume":"56","author":"HY Kim","year":"2014","unstructured":"Kim HY, Huang BX, Spector AA. Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res. 2014;56:1\u201318.","journal-title":"Prog Lipid Res"},{"key":"925_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","volume":"39","author":"PA Leventis","year":"2010","unstructured":"Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010;39:407\u201327.","journal-title":"Annu Rev Biophys"},{"key":"925_CR38","doi-asserted-by":"publisher","first-page":"e0164087","DOI":"10.1371\/journal.pone.0164087","volume":"11","author":"D Kotiya","year":"2016","unstructured":"Kotiya D, Jaiswal B, Ghose S, Kaul R, Datta K, Tyagi RK. Role of PXR in hepatic cancer: its influences on liver detoxification capacity and cancer progression. PLoS One. 2016;11:e0164087.","journal-title":"PLoS One"},{"key":"925_CR39","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/sj.bjc.6605677","volume":"102","author":"N Ouyang","year":"2010","unstructured":"Ouyang N, Ke S, Eagleton N, Xie Y, Chen G, Laffins B, et al. Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. Br J Cancer. 2010;102:1753\u201361.","journal-title":"Br J Cancer"},{"key":"925_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2014.01.026","volume":"347","author":"Y Niu","year":"2014","unstructured":"Niu Y, Wang Z, Huang H, Zhong S, Cai W, Xie Y, et al. Activated pregnane X receptor inhibits cervical cancer cell proliferation and tumorigenicity by inducing G2\/M cell-cycle arrest. Cancer Lett. 2014;347:88\u201397.","journal-title":"Cancer Lett"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00925-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00925-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00925-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:24:41Z","timestamp":1672831481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00925-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-00925-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}